Evidence map›Paper›PMID 41928470›Full record

ArticleMolecular therapy : the journal of the American Society of Gene Therapy2026

A reproducible and physiologically relevant human iPSC-derived platform for in vitro modeling of the neurocardiac junction.

Giada Cattelan, Claudia Altomare, Giovanna Gentile, Alexandros A Lavdas, Laura Sophie Frommelt, Chiara Volani, Luisa Foco, Pietro Girardi, Elisa Peducci, Amparo Guerrero Gerboles and 9 more

Abstract read
In one paragraph

Article in Molecular therapy : the journal of the American Society of Gene Therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Giada CattelanEurac Research, Institute for Biomedicine, 39100 Bolzano, Italy; Faculty of Engineering, Free University of Bolzano, 39100 Bolzano, Italy. Electronic address: giada.cattelan@eurac.edu.
Claudia AltomareCardiovascular Theranostics Group, Istituto Cardiocentro Ticino, Ente Ospedaliero Cantonale, 6900 Lugano, Switzerland; Institute for Translational Research, Faculty of Biomedical Sciences, Università Svizzera Italiana, Ente Ospedaliero Cantonale, 6500 Bellinzona, Switzerland; Euler Institute, Faculty of Biomedical Sciences, Università Svizzera Italiana, 6900 Lugano, Switzerland.
Giovanna GentileEurac Research, Institute for Biomedicine, 39100 Bolzano, Italy; Faculty of Engineering, Free University of Bolzano, 39100 Bolzano, Italy.
Alexandros A LavdasEurac Research, Institute for Biomedicine, 39100 Bolzano, Italy.
Laura Sophie FrommeltEurac Research, Institute for Biomedicine, 39100 Bolzano, Italy; Cardiovascular Biology Laboratory, ICGEB Trieste, 34149 Trieste, Italy; University of Trieste, Department of Medicine, Surgery, and Health Sciences, 34149 Trieste, Italy.
Chiara VolaniEurac Research, Institute for Biomedicine, 39100 Bolzano, Italy; The Cell Physiology MiLab, Department of Biosciences, Universitá Degli Studi di Milano, 20133 Milano, Italy.
Luisa FocoEurac Research, Institute for Biomedicine, 39100 Bolzano, Italy.
Pietro GirardiEurac Research, Institute for Biomedicine, 39100 Bolzano, Italy.
Elisa PeducciEurac Research, Institute for Biomedicine, 39100 Bolzano, Italy.
Amparo Guerrero GerbolesDepartment of Medicine and Surgery, University of Parma, 43124 Parma, Italy.
Michele MiragoliDepartment of Medicine and Surgery, University of Parma, 43124 Parma, Italy; IRCCS, Humanitas Research Hospital Department of Medicine, Via Rita Levi Montalcini 4, Pieve Emanuele, 20072 Milan, Italy.
Luisa PettiFaculty of Engineering, Free University of Bolzano, 39100 Bolzano, Italy.
Peter P PramstallerEurac Research, Institute for Biomedicine, 39100 Bolzano, Italy.
Lucio BarileCardiovascular Theranostics Group, Istituto Cardiocentro Ticino, Ente Ospedaliero Cantonale, 6900 Lugano, Switzerland; Institute for Translational Research, Faculty of Biomedical Sciences, Università Svizzera Italiana, Ente Ospedaliero Cantonale, 6500 Bellinzona, Switzerland; Euler Institute, Faculty of Biomedical Sciences, Università Svizzera Italiana, 6900 Lugano, Switzerland.
Serena ZacchignaCardiovascular Biology Laboratory, ICGEB Trieste, 34149 Trieste, Italy; University of Trieste, Department of Medicine, Surgery, and Health Sciences, 34149 Trieste, Italy.
Irene PichlerEurac Research, Institute for Biomedicine, 39100 Bolzano, Italy.
Alessandra RossiniEurac Research, Institute for Biomedicine, 39100 Bolzano, Italy.
Alessandra ZanonEurac Research, Institute for Biomedicine, 39100 Bolzano, Italy.
Marzia De BortoliEurac Research, Institute for Biomedicine, 39100 Bolzano, Italy. Electronic address: marzia.debortoli@eurac.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The cardiac autonomic nervous system is central to various cardiac diseases, yet its regulation in the human heart remains poorly understood due to the lack of reliable models. Here, we report the development of a neurocardiac co-culture system using human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) and sympathetic neurons (hiPSC-SNs). Both cell types were characterized molecularly and electrophysiologically and subsequently used for the establishment of the co-culture model in a two-well chambers insert, forming a dense axonal network connected with hiPSC-CMs. The co-culture demonstrated robust functional interactions: hiPSC-CMs maintained a stable beating rate, while hiPSC-SNs exhibited significantly increased firing activity after 7 days. Nicotine stimulation enhanced hiPSC-SN activity, resulting in an increased beating rate in co-cultured hiPSC-CMs, an effect that is absent in monoculture. This rise in the beats was abolished by nicotinic acetylcholine receptor blockade through α-bungarotoxin on hiPSC-SNs in co-culture. The β-blocker propranolol mitigated isoproterenol or nicotine effects on hiPSC-CMs. Using a fluorescent tracer, functional exocytosis and norepinephrine release was confirmed in hiPSC-SNs in co-culture. This novel neurocardiac model replicates neuronal control of cardiomyocytes and provides a new and robust platform for studying neuro-cardiac interactions. It represents a promising tool for advancing disease modeling and pharmacologic research in cardiac pathophysiology.

Indexed as

Induced Pluripotent Stem CellsMyocytes, CardiacNeuronsCell DifferentiationCells, CulturedCoculture TechniquesHumansNicotineSympathetic Nervous SystemNicotinecardiac autonomic nervous systemcardiac innervationco-culture modelhiPSChiPSC-derived cardiomyocyteshiPSC-derived sympathetic neuronshuman induced pluripotent stem cellsneurocardiobiology

Identifiers

PMID41928470
PMCPMC13464303

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.